神经系统在胃癌中的研究进展

王 少红1, 沈存 芳*2
1、青海大学研究生院
2、青海大学附属医院肿瘤内科

摘要


近年来，神经系统与肿瘤微环境的相互作用成为癌症研究的热点领域。研究表明，神经系统通过神经递质、神经营养因子和神经肽等分子机制参与胃癌的发生、发展和转移。交感神经和副交感神经在胃癌中发挥不同的调控作用，影响肿瘤生长和患者预后。基于神经系统与胃癌相互作用的研究，已开发出多种潜在的治疗策略，包括神经阻断疗法、神经递质调节和神经免疫调节等。深入理解神经系统在胃癌中的作用机制，将为胃癌的预防、诊断和治疗提供新的思路和方法。本文综述了神经系统在胃癌中的研究进展。

关键词


胃癌；神经系统；肿瘤微环境；神经递质；治疗策略

全文:

PDF


参考


[1]李茁钰，刘凯，张维汉，等.全球及中国胃癌的流行病学特点及趋势：2018-2022《全球癌症统计报告》解读[J].中国普外基础与临床杂志，2024，31（10）：1236-1245.

[2]K.L. Mueller, Cancer immunology and immunotherapy. Realizing the promise.Introduction, Science 348 (6230) (2015) 54-55.

[3]D.Hirata, E. Sahai, Cold Spring Harb. Perspect. Med. 2017, 7,a026781.

[4]E.Quail, J. A. Joyce, Nat. Med. 2013, 19, 1423.

[5]R. Baghban, L. Roshangar, R. Jahanban‐Esfahlan, K. Seidi, A.Ebrahimi‐Kalan, M. Jaymand, S. Kolahian, T. Javaheri, P.Zare, Cell Commun. Signal. 2020, 18, 59.

[6]P. Jobling, et al., Nerve-Cancer cell cross-talk: a novel promoter of tumor pro-gression, Cancer Res. 75 (9) (2015) 1777-1781.

[7]S. Faulkner, P. Jobling, B. March, C. C. Jiang, H. Hon-dermarck, Cancer Discov. 2019, 9, 702.

[8]M. Monje, J. C. Borniger, N. J. D’Silva, B. Deneen, P. B. Dirks,F. Fattahi, P. S. Frenette, L. Garzia, D. H. Gutmann, D.Hanahan, S. L. Hervey‐Jumper, H. Hondermarck, J. B. Hurov,A. Kepecs, S. M. Knox, A. C. Lloyd, C. Magnon, J. L. Saloman,R. A. Segal, E. K. Sloan, X. Sun, M. D. Taylor, K. J. Tracey,L. C. Trotman, D. A. Tuveson, T. C. Wang, R. A. White, F.Winkler, Cell 2020, 181, 219.

[9]Ke Wang, Xin-hui Zhao, Jun Liu, Rui Zhang, Ji-peng Li,Nervous system and gastric cancer,Biochimica et Biophysica Acta (BBA) - Reviews on Cancer,Volume 1873,Issue 1,2020,188313.

[10]Wan, C.; Yan, X.; Hu, B.; Zhang, X. Emerging Roles of the Nervous System in Gastrointestinal Cancer Development. Cancers 2022, 14, 3722.

[11]T.Shan, et al., Novel regulatory program for norepinephrine-induced epithelial-mesenchymal transition in gastric adenocarcinoma cell lines, Cancer Sci. 105 (7)(2014) 847-856.

[12]Y.J. Lu, et al., Isoprenaline induces epithelial-mesenchymal transition in gastric cancer cells, Mol. Cell. Biochem. 408 (1-2) (2015) 1-13.

[13]A. Kamiya, et al., Prognostic value of tropomyosin-related kinases a, B, and C in gastric cancer, Clin. Transl. Oncol. 18 (6) (2016) 599-607.

[14]A.J. Xu, et al., MicroRNA744 inhibits tumor cell proliferation and invasion of gastric cancer via targeting brainderived neurotrophic factor, Mol. Med. Rep. 16(4) (2017) 5055-5061.

[15]D. Ding, et al., miR-613 inhibits gastric cancer progression through repressing brain derived neurotrophic factor, Exp. Ther. Med. 15 (2) (2018) 1735-1741.

[16]F. Feng, et al., Substance P immunoreactive nerve fibres are related to gastric cancer differentiation status and could promote proliferation and migration of

[17]gastric cancer cells, Cell Biol. Int. 35 (6) (2011) 623-629.

[18]Pouya, F.D., Rasmi, Y. & Asl, E.R. Role of Neurotransmitters and Neuropeptides in Breast Cancer Metastasis. Biochem. Moscow Suppl. Ser. A 14, 107-116 (2020).

[19]Itami, T., Kurokawa, Y., Hagi, T. et al. Sympathetic innervation induced by nerve growth factor promotes malignant transformation in gastric cancer. Sci Rep 15, 3824 (2025).


Refbacks

  • 当前没有refback。